Mr. Berkowitz has extensive experience in patent litigation matters involving the pharmaceutical industry and specifically involving Abbreviated New Drug Applications (ANDA) under the Hatch-Waxman Act for generic pharmaceutical companies. In addition to being an active member of the firm's ANDA Litigation team, he is also registered to practice as a patent attorney before the United States Patent and Trademark Office and has represented clients before the United States Trademark Trial and Appeal Board and the United States Patent and Trademark Office Board of Patent Appeals and Interferences. Mr. Berkowitz is a member of the Board of Governors of the Philadelphia Bar Association. He also currently co-chairs the Philadelphia Bar Association's Intellectual Property Committee and serves on its Israel Exchange Committee. Before becoming an attorney, Mr. Berkowitz worked for five years as an engineer with the Space Systems Division of the General Electric Company.
Unigene Labs, Inc. v. Apotex, Inc. (S.D.N.Y. 2006) represent generic defendant concerning nasal osteoporosis pharmaceutical drug, Fortical® (calcitonin)
Biovail Laboratories, Inc. v. TorPharm, Inc. (E.D. Pa. 2004) represented generic manufacturer regarding blood pressure medication Tiazac® (diltiazem hydrochloride)
Sanofi-Aventis, Sanofi-Synthelabo, Inc., and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership v. Apotex, Inc. (S.D.N.Y. 2003) represented generic in ANDA litigation on anti-platelet medication Plavix® (clopidogrel bisulphate)
Biovail Laboratories, Inc. v. TorPharm, Inc. (N.D. Ill. 2003) represented generic manufacturer in suit involving calcium channel blocker medication for hypertension Cardizem CD® (diltiazem hydrochloride)
Novartis Pharma. v. Apotex, Inc. (S.D.N.Y. 2002) represented generic in ANDA litigation concerning nasal osteoporosis pharmaceutical Miacalcin® (calcitonin)
Apotex, Inc. v. Eon Labs Manufacturing, Inc. (S.D.N.Y. 2002), represented patentee in litigation involving generic anti-rejection medication cyclosporine
Glaxo Wellcome, Inc. v. Pharmadyne Corp. (D. Md. 1996) represented ANDA applicant in patent suit involving liquid dosage form of Zantac® (ranitidine hydrochloride)
Pennsylvania
United States Supreme Court
United States Court of Appeals for the Federal Circuit
United States District Court for the Eastern District of Pennsylvania
United States Patent and Trademark Office
American Jurisprudence Award in Legal Methods and Moot Court, Widener University School of Law (1991)
Pennsylvania SuperLawyer by Philadelphia Magazine, 2006-2007
Widener University School of Law: J.D.
Lehigh University: B.S. Engineering
RETURN TO TOP OF PAGE
|
|
MICHAEL J. BERKOWITZ partner
INDUSTRIES SERVED
Architectural & Building Materials
Computers
Consumer Products
Engineering and Construction
Food Products
Medical Products
Metallurgy and Materials
Pharmaceutical
ADMITTED TO PRACTICE
Pennsylvania
U.S. Supreme Court
U.S. Court of Appeals for the Federal Circuit
U.S. District Court for the Eastern District of Pennsylvania
U.S. Patent and Trademark Office
AWARDS & RECOGNITION
Named Pennsylvania SuperLawyer by Philadelphia Magazine, 2006, 2007
American Jurisprudence Award in Legal Methods and Moot Court
EDUCATIONAL
BACKGROUND
Lehigh University: B.S. Engineering
Widener University School of Law: J.D. (American Jurisprudence Award in Legal Methods and Moot Court)
|
|
